London: A groundbreaking scientific project to develop the synthetic human genome has begun in the UK, supported by a £10 million ($12.6 million) grant from the Wellcome Trust. The initiative seeks to build synthetic human genome structures from scratch in laboratory conditions, marking a major leap beyond the Human Genome Project.
Led by top institutions including the MRC Laboratory of Molecular Biology and the Wellcome Sanger Institute, the effort builds on progress made through the Human Genome Project. Now, researchers plan to move from reading DNA to synthesizing it, molecule by molecule, starting with entire human chromosomes.
Dr. Julian Sale, one of the leading scientists on the project, said that the technology opens new possibilities in regenerative medicine and healthy aging. “We are looking at therapies that will improve people’s lives as they age, that will lead to healthier aging with less disease,” Dr. Sale highlighted, adding that scientists hope to engineer disease-resistant cells for use in the heart, liver, and immune system.
Professor Matthew Hurles noted that the initiative will allow researchers to test how DNA works in new ways. “Building DNA from scratch allows us to test out how DNA really functions and explore new scientific theories,” Prof Matthew remarked.
However, the synthetic human genome project has sparked ethical concerns. Critics warn that while the current work is confined to laboratories, the technology may be misused in the future for harmful purposes like biological weapons or unauthorized genetic modifications.
Professor Bill Earnshaw emphasized the challenges of global regulation, saying that if certain actors acquire the tools, “we could have a set of restrictions now, but if an organization who has access to appropriate machinery decided to start synthesizing anything, I don’t think we could stop them.”
To address public concern, the project will be accompanied by a parallel social science program led by the University of Kent, gathering feedback from social scientists, ethicists, and the wider public.
Dr. Tom Collins, who approved the Wellcome Trust’s funding, said that inaction posed a greater risk. “This technology is going to be developed one day, so by doing it now we are at least trying to do it in as responsible a way as possible,” Dr. Collins added.
Although researchers affirm that no synthetic life will be created, the ability to build DNA from scratch gives scientists unprecedented control over human genetic systems.
The synthetic human genome project stands at the intersection of innovation and ethics, with the potential to transform medicine, but only if guided with transparency and care.
ALSO READ | Vietnam scales back death penalty in major legal reform
